Absci Corporation (ABSI )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ABSI
- Company Absci Corporation
- Price $4.35
- Changes Percentage 17.57
- Change 0.65
- Day Low $3.65
- Day High $4.38
- Year High $6.72
- Year Low $2.45
- Market Cap $499,623,600
- Price Avg 50 EMA (D) $3.2
- Price Avg 200 EMA (D) $3.87
- Exchange NASDAQ
- Volume 12,306,012
- Average Volume 3,949,375
- Open $3.7
- Previous Close $3.7
- EPS -0.93
- PE -4.68
- Earnings Announcement 2025-03-19 12:30:00
- Shares Outstanding $114,856,000
Company brief: ABSCI CORPORATION (ABSI )
- Healthcare
- Biotechnology
- Mr. Sean McClain
- https://www.absci.com
- US
- N/A
- 07-22-2021
- US00091E1091
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.